-
公开(公告)号:PT1140888E
公开(公告)日:2003-09-30
申请号:PT99965226
申请日:1999-12-10
Applicant: VERTEX PHARMA SAN DIEGO LLC
Inventor: ZLOKARNIK GREGOR , MAKINGS LEWIS
IPC: G01N37/00 , A61K45/00 , A61P43/00 , C07D219/06 , C07D265/38 , C07D311/16 , C07D311/82 , C07D493/10 , C12Q1/26
Abstract: The invention provides a compound, useful as an optical probe or sensor of the activity of at least one cytochrome P450 enzyme, and methods of using the compound to screen candidate drugs, and candidate drugs identified by these methods. The optical probe of the invention is a compound having the generic structure Y-L-Q, wherein Y is selected from the group consisting of Q as herein defined, saturated C 1 -C 20 alkyl, unsaturated C 1 -C 20 alkenyl, unsaturated C 1 -C 20 alkynyl, substituted saturated C 1 -C 20 alkyl, substituted unsaturated C 1 -C 20 alkenyl, substituted unsaturated C 1 -C 20 alkynyl, C 1 -C 20 cycloalkyl, C 1 -C 20 cycloalkenyl, substituted saturated C 1 -C 20 cycloalkyl, substituted unsaturated C 1 -C 20 cycloalkenyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl; L is selected from the group of (-OCR 2 H) p -, wherein for each p, all R 2 are separately selected from the group consisting of a hydrogen atom, saturated C 1 -C 20 alkyl, unsaturated C 1 -C 20 alkenyl, unsaturated C 1 -C 20 alkynyl, substituted saturated C 1 -C 20 alkyl, substituted unsaturated C 1 -C 20 alkenyl, substituted unsaturated C 1 -C 20 alkynyl, C 1 -C 20 cycloalkyl, C 1 -C 20 cycloalkenyl, substituted saturated C 1 -C 20 cycloalkyl, substituted unsaturated C 1 -C 20 cycloalkenyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, and p is a positive integer no greater than twelve; and Q is a chemical moiety that gives rise to optical properties in its hydroxy or hydroxylate, phenol or phenoxide form that are different from the optical properties that arise from its ether form. Most preferably, p is one, R 2 is hydrogen, and Q is the ether form of a phenoxide fluorophore.
-
公开(公告)号:DE69907962D1
公开(公告)日:2003-06-18
申请号:DE69907962
申请日:1999-12-10
Applicant: VERTEX PHARMA SAN DIEGO LLC
Inventor: MAKINGS LEWIS , ZLOKARNIK GREGOR
IPC: G01N37/00 , A61K45/00 , A61P43/00 , C07D219/06 , C07D265/38 , C07D311/16 , C07D311/82 , C07D493/10 , C12Q1/26
Abstract: The invention provides a compound, useful as an optical probe or sensor of the activity of at least one cytochrome P450 enzyme, and methods of using the compound to screen candidate drugs, and candidate drugs identified by these methods. The optical probe of the invention is a compound having the generic structure Y-L-Q, wherein Y is selected from the group consisting of Q as herein defined, saturated C 1 -C 20 alkyl, unsaturated C 1 -C 20 alkenyl, unsaturated C 1 -C 20 alkynyl, substituted saturated C 1 -C 20 alkyl, substituted unsaturated C 1 -C 20 alkenyl, substituted unsaturated C 1 -C 20 alkynyl, C 1 -C 20 cycloalkyl, C 1 -C 20 cycloalkenyl, substituted saturated C 1 -C 20 cycloalkyl, substituted unsaturated C 1 -C 20 cycloalkenyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl; L is selected from the group of (-OCR 2 H) p -, wherein for each p, all R 2 are separately selected from the group consisting of a hydrogen atom, saturated C 1 -C 20 alkyl, unsaturated C 1 -C 20 alkenyl, unsaturated C 1 -C 20 alkynyl, substituted saturated C 1 -C 20 alkyl, substituted unsaturated C 1 -C 20 alkenyl, substituted unsaturated C 1 -C 20 alkynyl, C 1 -C 20 cycloalkyl, C 1 -C 20 cycloalkenyl, substituted saturated C 1 -C 20 cycloalkyl, substituted unsaturated C 1 -C 20 cycloalkenyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, and p is a positive integer no greater than twelve; and Q is a chemical moiety that gives rise to optical properties in its hydroxy or hydroxylate, phenol or phenoxide form that are different from the optical properties that arise from its ether form. Most preferably, p is one, R 2 is hydrogen, and Q is the ether form of a phenoxide fluorophore.
-
公开(公告)号:ES2718273T5
公开(公告)日:2025-02-06
申请号:ES10708442
申请日:2010-02-18
Applicant: VERTEX PHARMA
-
公开(公告)号:ME03356B
公开(公告)日:2019-10-20
申请号:MEP10119
申请日:2010-02-18
Applicant: VERTEX PHARMA
-
公开(公告)号:LT2464337T
公开(公告)日:2019-05-10
申请号:LT10708442
申请日:2010-02-18
Applicant: VERTEX PHARMA
-
公开(公告)号:HUE038854T2
公开(公告)日:2018-12-28
申请号:HUE10710748
申请日:2010-03-19
Applicant: VERTEX PHARMA
Inventor: YANG XIAOQING , HADIDA RUAH SARA , GROOTENHUIS PETER , VAN GOOR FREDRICK , BOTFIELD MARTYN , ZLOKARNIK GREGOR
-
公开(公告)号:ES2683633T3
公开(公告)日:2018-09-27
申请号:ES10710748
申请日:2010-03-19
Applicant: VERTEX PHARMA
Inventor: YANG XIAOQING , HADIDA RUAH SARA , GROOTENHUIS PETER , VAN GOOR FREDRICK , BOTFIELD MARTYN , ZLOKARNIK GREGOR
IPC: C07D215/233 , A61K31/47 , A61P3/00
Abstract: Un compuesto de Fórmula I:**Fórmula** o una sal farmacéuticamente aceptable del mismo, en donde R es COOH o CH2OH.
-
公开(公告)号:AU2018204671A1
公开(公告)日:2018-07-12
申请号:AU2018204671
申请日:2018-06-27
Applicant: VERTEX PHARMA
Inventor: DEMATTEI JOHN , LOOKER ADAM R , NEUBERT-LANGILLE BOBBIANNA J , TRUDEAU MARTIN , ROEPER STEFANIE , RYAN MICHAEL P , YAP GUERETTE DAHRIKA MILFRED LAO , KRUEGER BRIAN R , GROOTENHUIS PETER D J , VAN GOOR FREDRICK F , BOTFIELD MARTYN C , ZLOKARNIK GREGOR
IPC: C07D215/233
Abstract: The invention provides a process for the preparation of a compound of Formula 1, N H (Rx-X H R2 Formula 1 comprising coupling a carboxylic acid of Formula 2 (Rx-X OH Formula 2 with an aniline of Formula 3 Formula 3 in the presence of a coupling agent.
-
89.
公开(公告)号:ES2654414T3
公开(公告)日:2018-02-13
申请号:ES14182117
申请日:2010-03-19
Applicant: VERTEX PHARMA
Inventor: DEMATTEI JOHN , LOOKER ADAM R , NEUBERT LANGILLE BOBBIANA , TRUDEAU MARTIN , ROPER STEFANIE , RYAN MICHAEL , YAP DAHRIKA MILFRED LAO , KRUEGER BRIAN R , GROOTENHUIS PETER D J , VAN GROOR FREDERICK F , BOTFIELD MARTYN C , ZLOKARNIK GREGOR
IPC: C07D215/233
Abstract: Un proceso para la preparación de un compuesto de Fórmula 8 **(Ver fórmula)** que comprende nitrar un compuesto de Fórmula 7 usando una mezcla de ácido sulfúrico y ácido nítrico en presencia de diclorometano **(Ver fórmula)** en el que PG es un grupo protector y R2 y R4 son cada uno terc-butilo, y en el que el compuesto nitro de Fórmula 8 se purifica por cristalización, en el que PG es propoxiformilo, metanosulfonilo, 4-nitro-benzoílo, etoxiformilo, butoxiformilo, t-butoxiformilo, i-propoxiformilo o metoxiformilo.
-
90.
公开(公告)号:CY1116954T1
公开(公告)日:2017-04-05
申请号:CY151101043
申请日:2015-11-19
Applicant: VERTEX PHARMA
Inventor: DEMATTEI JOHN , LOOKER ADAM R , NEUBERT-LANGILLE BOBBIANNA , TRUDEAU MARTIN , ROEPER STEFANIE , RYAN MICHAEL P , YAP DAHRIKA MILFRED LAO , KRUEGER BRIAN R , GROOTENHUIS PETER D J , VAN GOOR FREDERICK F , BOTFIELD MARTYN C , ZLOKARNIK GREGOR
IPC: C07D215/233
Abstract: ΗεφεύρεσηπαρέχειμίαμέθοδογιατηνπαρασκευήμίαςένωσηςΤύπου 1•πουπεριλαμβάνεισύζευξηενόςκαρβοξυλικούοξέοςΤύπου 2 μεμίαανιλίνηΤύπου 3•παρουσίαενόςπαράγοντασύζευξης.
-
-
-
-
-
-
-
-
-